Ruxolitinib in Thrombocythemia and Polycythemia Vera — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(4 sites)
United States
Massachusetts General Hospital, Boston, Massachusetts Beth-Israel Deaconess Medical Center, Boston, Massachusetts Dana Farber Cancer Institute, Boston, Massachusetts Massachusetts General North Shore Cancer Center, Danvers, Massachusetts Last updated January 2026